US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist

4.235
-1.025-19.49%

Close Feb 28 16:00 ET

4.230
-0.005-0.12%

Post 19:59 ET

1.39BMarket Cap-3.31P/E (TTM)

Iovance Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iovance Biotherapeutics Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	72.17M	73.69M	+1.52M
Beat Est.	+14873.88%	+15189.21%	+2.11%
EPS	-0.27	-0.26	+0.01
Beat Est.	+39.74%	+42.22%	+4.09%

Analyst Rating

Strong Buy

Mar 1, 2025

Iovance Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 102.486M	--
--	2025/Q1	-- / 84.073M	--
Feb 27, 2025	2024/Q4	73.694M / 72.174M	--
Nov 7, 2024	2024/Q3	58.555M / 53.818M	--
Aug 8, 2024	2024/Q2	31.106M / 24.561M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 102.486M--

--2025/Q1-- / 84.073M--

Feb 27, 20252024/Q473.694M / 72.174M--

Nov 7, 20242024/Q358.555M / 53.818M--

Aug 8, 20242024/Q231.106M / 24.561M--

Unlock Free Earnings Estimates

Open Account

Iovance Biotherapeutics Earnings Reports

Iovance Biotherapeutics | 10-K: FY2024 Annual Report

Feb 27 17:16 ET

Iovance Biotherapeutics | 8-K: Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024

Feb 27 16:05 ET

Iovance Biotherapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 17:23 ET

Iovance Biotherapeutics | 8-K: Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

Nov 7, 2024 16:09 ET